Signed · France · Pharma and biotech
Revvity agrees to acquire Human Cell Design.
Revvity, based in Waltham, Massachusetts, signed a definitive agreement on 9 September 2026 to acquire Human Cell Design, a Toulouse, France, biotechnology company that makes human cell models for diabetes, obesity and other metabolic disease research. It was signed on 9 September 2026. It had not completed by 28 October 2026.
Signing 9 September 2026
- Buyer
- Revvity, Inc. ·Waltham, United States
- Target
- Human Cell Design ·Toulouse, France
- Type
- Acquisition
- Announced
- 9 September 2026
- Signed
- 9 September 2026
- Value
- Not disclosed
- People
- Not stated in the release
- Last checked
- 28 October 2026
The people side in France
- A French target with 50 or more employees consults its works council (CSE) before any binding decision. Labour Code (Code du travail), articles L2312-8 and L2312-14
- In a sale of the business, a merger or another change in the employer's legal situation, all employment contracts in force continue with the new employer. Labour Code (Code du travail), article L1224-1
- Where a deal meets the French merger control thresholds, the parties wait for the final decision of the Autorité de la concurrence before completing it. Autorité de la concurrence: Contrôle des concentrations
- In sensitive activities, prior authorisation is needed for a foreign buyer taking control or a business line, or a non-EU/EEA buyer crossing 25% of votes (10% if listed). Direction générale du Trésor: Les conditions d'une opération soumise à autorisation préalable
- A foreign company without an establishment in France that hires staff there declares them and pays their social contributions in France, through the Urssaf Foreign Companies service. Urssaf: Foreign companies service
- Where the deal needs EU merger clearance, the buyer may not implement it before clearance. EU Merger Regulation (Council Regulation (EC) No 139/2004), article 7
Related deals
- 3 Sep
Resonant Clinical Solutionsto
Creapharm Bioservicesdeal page: Resonant Clinical Solutions acquires Creapharm BioservicesCompleted
not statedSigningDay 100 - 22 Oct
Climb Global Solutions, Inc.to
NeoVAD SASdeal page: Climb Global Solutions acquires NeoVADCompleted
not statedSigningDay 100 - 6 Oct
Bioworld Merchandising, Inc.to
Chaulnes Textile Industries (CTI)deal page: Bioworld acquires CTICompleted
not statedSigningDay 100 - 23 Sep
Arcturus Therapeutics Holdings Inc.to
myNEO Therapeuticsdeal page: Arcturus Therapeutics agrees to acquire myNEOSigned
not statedSigningDay 100